A New York life investents company
CANDRIAM Switzerland LLC, today with offices in Zurich and Geneva, has been providing services to Swiss clients since 1999.
Candriam is a leading global asset manager with a strong European presence based on 20 years of experience. With investment centers in Brussels, Paris, Luxembourg and London, our conviction-driven investment solutions cover five key areas:
- Fixed Income
- Absolute Performance Strategies
- Sustainable Investments
- Advanced Asset Allocation
Candriam is part of New York Life Investments, one of the world’s largest asset management groups with approximately CHF 577 billion (end June 2019) in assets under management. In addition to its own strategies, Candriam is also the European distributor for the range of products of New York Life Investments boutiques which are highly specialized in Private Markets Investments solutions such as Real Estate, Private Debt and Private Equity as well as US Fixed Income.
Candriam currently accounts for almost 25% of New York Life Investments’ assets under management.
Candriam stands for “Conviction And Responsibility in Asset Management”: conviction-based investment decisions and a sense of responsibility to our clients run through everything we do.
In addition to standard strategies, at Candriam, we offer a specialist SRI product range based on the joint work of our team of dedicated SRI analysts and each of our investment teams. Our SRI funds cover equities, fixed income and asset allocation strategies and the European, North American, Asia-Pacific and emerging market regions.
Our approach towards SRI involves selecting firms with leading Environmental, Social and Governance (ESG) practices in their field, direct dialogue with companies to encourage them to improve their behavior, and a proxy voting process that we have been refining since 2003.
Overall, 32% of our total assets under management are invested in SRI strategies (as of June 2019).
In addition to our investment teams located in Brussels, Paris, Luxembourg and London, we have teams on the ground in nine European countries, close to the clients that we serve.
Stability and dynamism have kept Candriam's core management team together for more than 15 years. The company is headed by an executive committee composed of 9 people presided over by Naïm Abou-Jaoudé, CEO. Vincent Hamelink, CFA, is CIO Fundamental Investments, Fabrice Cuchet is CIO Alternative Investments and Renato Guerriero is Global Head of Distribution.
Founded in 1998
Total Employees: More than 500
CHF 137.5 AuM
(figures as of end of June 2019)
Mr Jörg Allenspach, Head of Candriam Switzerland
Tel +41 43 547 01 41
– Zürich Office
Mr Gauthier de la Rochefoucauld, Romandie Market Region, Senior Client Relationship Manager
Tel + 41 22 707 90 01
– Geneva Office
Mr Thomas Kälin, Swiss-German Market Region, Senior Client Relationship Manager
Tel + 41 43 547 01 42
– Zürich Office
"The time has now come to assess the speed at which our economies can recover, but also to understand the more structural changes that took place within them."
European power generation companies are critical actors for the Just Transition to renewable energy. Candriam ESG analysts have surveyed and evaluated whether, and how, these companies are integrating the social consequences into their planning and decisions.
Since the Global Financial Crisis, Growth equities have significantly outperformed Value equities in Europe. The Value style has suffered from low and falling interest rates. But it was not a straight line!
"Do weak oil prices explain the ESG outperformance, considering that many ESG strategies were underweight the energy sector? Being underweight in an underperforming sector clearly played a role, but not one big enough to explain the ESG outperformance."
Candriam Equities L Oncology Impact souffle sa première bougie, l’heure d’un premier bilan.prévention et ses conséquences.
Candriam Equities L Oncology Impact celebrates its first year: time for a progress update
"The cost to society is reaching an unbearable level – estimates suggest a full 1% to 2% of world GDP in health costs due to bad diets. The cost is both large, and at the moment, largely hidden."
The US is currently experiencing an exceptional period from a microeconomic point of view.